Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Divi's Laboratories Ltd.
Swot
Divi's Laboratories Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Divi's Laboratories Ltd. has 17 Strengths, 9 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(17)
Weakness
(9)
Opportunity
(5)
Threats
(1)
Others
(3)
MACD Crossover Above Signal Line
Positive Breakout Third Resistance ( LTP > R3)
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years
Companies with high TTM EPS Growth
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
High Volume, High Gain
MACD crossed above signal line previous end of day
Top Gainers
Volume Shockers
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
RSI indicating price weakness
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
Broker downgrades in price or recommendation in the past one month
Expensive Performers (DVM)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)